Advyzom

Advyzom was a boutique consulting firm founded in 2011 specializing in strategic regulatory affairs and development advice for biotechnology/pharmaceutical companies. With approximately thirty specialists experienced across multiple therapeutic areas—including oncology, neurology, immunology—they provided end-to-end support from early-stage development through post-marketing activities. Their services included acting as US Agent to the FDA; authoring key submission documents such as INDs/NDAs/BLAs; supporting global eCTD filings; advising on special designations like Fast Track/orphan status; and integrating seamlessly into client product teams. In September 2024 they were acquired by Danforth Advisors to form an expanded offering covering both financial/corporate advisory and comprehensive clinical/regulatory solutions for life sciences clients.